Related Experiment Video
Updated: Dec 28, 2025

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance
Zhuan Zhou1, Xinxin Song1, Junlong Jack Chi2
1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States.
Abstract:
KLF4 plays an important role in orchestrating a variety of cellular events, including cell-fate decision, genome stability and apoptosis. Its deregulation is correlated with human diseases such as breast cancer and gastrointestinal cancer. Results from recent biochemical studies have revealed that KLF4 is tightly regulated by posttranslational modifications. Here we report a new finding that KLF4 orchestrates estrogen receptor signaling and facilitates endocrine resistance. We also uncovered the underlying mechanism that alteration of KLF4 by posttranslational modifications such as phosphorylation and ubiquitylation changes tumor cell response to endocrine therapy drugs. IHC analyses using based on human breast cancer specimens showed the accumulation of KLF4 protein in ER-positive breast cancer tissues. Elevated KLF4 expression significantly correlated with prognosis and endocrine resistance. Our drug screening for suppressing KLF4 protein expression led to identification of Src kinase to be a critical player in modulating KLF4-mediated tamoxifen resistance. Depletion of VHL (von Hippel-Lindau tumor suppressor), a ubiquitin E3 ligase for KLF4, reduces tumor cell sensitivity to tamoxifen. We demonstrated phosphorylation of VHL by Src enhances proteolysis of VHL that in turn leads to upregulation of KLF4 and increases endocrine resistance. Suppression of Src-VHL-KLF4 cascade by Src inhibitor or enhancement of VHL-KLF4 ubiquitination by TAT-KLF4 (371-420AAa) peptides re-sensitizes tamoxifen-resistant breast cancer cells to tamoxifen treatment. Taken together, our findings demonstrate a novel role for KLF4 in modulating endocrine resistance via the Src-VHL-KLF4 axis.
Insights
Krüppel-like factor 4 (KLF4) drives endocrine resistance in breast cancer by coordinating estrogen receptor signaling. Targeting the Src-VHL-KLF4 pathway can re-sensitize resistant tumors to tamoxifen.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Krüppel-like factor 4 (KLF4) is crucial for cellular events and implicated in cancers like breast cancer.
- Posttranslational modifications regulate KLF4 activity, impacting its role in disease.
- KLF4 deregulation is linked to poor prognosis and treatment resistance.
Purpose of the Study:
- To investigate the role of KLF4 in estrogen receptor signaling and endocrine resistance in breast cancer.
- To elucidate the molecular mechanisms by which KLF4 influences response to endocrine therapy.
- To identify potential therapeutic targets for overcoming tamoxifen resistance.
Main Methods:
- Immunohistochemistry (IHC) analysis of human breast cancer specimens.
- Drug screening to identify modulators of KLF4 protein expression.
- Biochemical assays to study protein interactions and modifications (phosphorylation, ubiquitylation).
Main Results:
- KLF4 protein accumulates in ER-positive breast cancer tissues and correlates with poor prognosis and endocrine resistance.
- Src kinase activity and VHL (von Hippel-Lindau tumor suppressor) ubiquitylation regulate KLF4 levels and tamoxifen resistance.
- Phosphorylation of VHL by Src enhances KLF4-mediated endocrine resistance.
- Targeting the Src-VHL-KLF4 axis with inhibitors or peptides re-sensitizes resistant cells.
Conclusions:
- KLF4 plays a novel role in mediating endocrine resistance in breast cancer.
- The Src-VHL-KLF4 signaling axis is a critical regulator of tamoxifen resistance.
- Interventions targeting this pathway hold promise for treating endocrine-resistant breast cancer.
More Related Videos
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
10:28Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Related Concept Videos
Regulation of Hormone Secretion
Humoral...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Master Transcription Regulators
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors